Journals / Klinik Tıp Bilimleri / 2018 / Cilt: 6 - Sayı: 4

Type 1 Diabetes and Osteoporosis

Tip 1 Diyabet ve Osteoporoz

Pages
10–14
Publication Date
2018-04-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is been thougt that the early diagnosis and teratment ofosteoporosis may decrease the risk of fracture which is an important comorbidite, in Type 1 diabetic patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractThe complications like cardiovascular diseases, osteoporosis and conginif detoriations that are seen in elderly has became more important as the increase oflong life expactance among Type 1 Diabetes mellitus (DM).
📊
Key Findings & Data:Also insüline deficiency in Type 1 DM isprovided to be a negative factor on bone stracture.
💡
Conclusion & Impact:It is been thougt that the early diagnosis and teratment ofosteoporosis may decrease the risk of fracture which is an important comorbidite, in Type 1 diabetic patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Tip 1 diyabet · osteoporoz · kırık

Abstract

AbstractThe complications like cardiovascular diseases, osteoporosis and conginif detoriations that are seen in elderly has became more important as the increase oflong life expactance among Type 1 Diabetes mellitus (DM). It is very well known that long duration of diabetes and glisemic control is associated with bone mineral density and bone fragility risk. Also insüline deficiency in Type 1 DM isprovided to be a negative factor on bone stracture. As a result likely in Type 2DM, osteoporosis is more common among Type 1 DM than normal population and diagnosis delates. It is been thougt that the early diagnosis and teratment ofosteoporosis may decrease the risk of fracture which is an important comorbidite, in Type 1 diabetic patients.

Özet

ÖzTip 1 Diyabet mellitus (DM) hastalarında uzamış yaşam beklentisi ile kardiyovasküler hastalıklar, osteoporoz ve kognitif bozulmalar gibi yaşa bağlı gelişebilecek komplikasyolar daha çok önem kazanmaya başlamıştır. Tip 1 Dm ve osteoporoz ilişkisi oldukça karmaşık olup bu konuda yapılmış pek çok çalışma bulunmaktadır. Glisemik kontrol ve uzun süreli diyabetin, düşük kemik mineral yoğunluğu (KMD) ve kemik fraktür riski ile ilişkili olduğu bilinmektedir. AyrıcaTip 1 diyabetteki mevcut insulin eksikliğinin kemik yapısının oluşumu üzerinenegatif etkisi olduğu da ileri sürülmüştür. Sonuç olarak tıpkı Tip 2 Dm olduğugibi Tip 1 DM hastalarında da osteoporoz riski normal popülasyondan yüksektir ve tanı koymada gecikme yaşanmaktadır. Bu nedenle yaşam beklentisi uza-mış olan Tip 1 DM’li hasta grubunda bu hastalığın erken tanınıp tedavi edilmesinin önemli bir komorbidite olan fraktür riskinde azalmaya neden olacağı düşünülmektedir.

🔖

Cite This Article

KESKİN, D. D. F. E. (2018). Type 1 Diabetes and Osteoporosis. Klinik Tıp Bilimleri, Cilt: 6 - Sayı: 4, 10–14. https://ajindex.com/articles/838226

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kaynaklar 1.Shah VN, Shah CS, Snell-Bergeon JK. Type 1 diabetesand risk of fracture: meta-analysis and review of the li-terature. Diabet Med. 2015
  2. 32(9):1134-42. 2.Shah VN, Moser EG, Blau A, Dhingra M, Garg SK. Thefuture of basal insulin. Diabetes Technol Ther.2013
  3. 15(9):727-32. 3.Atkinson MA, Eisenbarth GS, Michels AW. Type 1 dia-betes. Lancet. 2014
  4. 383(9911):69-82. 4.Miller RG, Secrest AM, Sharma RK, Songer TJ, OrchardTJ. Improvements in the life expectancy of type 1 diabe-tes: the Pittsburgh Epidemiology of Diabetes Complica-tions study cohort. Diabetes. 2012
  5. 61(11): 2987-92. 5.Alexopoulou O, Jamart J, Devogelaer JP, Brichard S,de Nayer P, Buysschaert M. Bone density and markersof bone remodeling in type 1 male diabetic patients. Dia-betes Metab. 2006
  6. 32(5 Pt 1):453-8. 6.Hadjidakis DJ, Raptis AE, Sfakianakis M, Mylonakis A,Raptis SA. Bone mineral density of both genders in Type1 diabetes according to bone composition. J DiabetesComplications. 2006
  7. 20(5):302-7. 7.Vestergaard P. Discrepancies in bone mineral density andfracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int. 2007
  8. 18(4):427-44. 8.Liu EY, Wactawski-Wende J, Donahue RP, Dmochows-ki J, Hovey KM, Quattrin T. Does low bone mineral den-sity start in post-teenage years in women with type 1 dia-betes? Diabetes Care. 2003
  9. 26(8):2365-9. 9.Rakic V, Davis WA, Chubb SA, Islam FM, Prince RL,Davis TM. Bone mineral density and its determinantsin diabetes: the Fremantle Diabetes Study. Diabetolo-gia. 2006
  10. 49(5):863-71. 10.Lunt H, Florkowski CM, Cundy T, Kendall D, BrownLJ, Elliot JR, et al. A population-based study of bonemineral density in women with longstanding type 1 (in-sulin dependent) diabetes. Diabetes Res Clin Pract.1998
  11. 40(1):31-8. 11.Olmos JM, Perez-Castrillon JL, Garcia MT, Garrido JC,Amado JA, Gonzalez-Macias J. Bone densitometry and bi-ochemical bone remodeling markers in type 1 diabetes mel-litus. Bone Miner. 1994
  12. 26(1):1-8. 12.Rozadilla A, Nolla JM, Montana E, Fiter J, Gomez-Va-quero C, Soler J, et al. Bone mineral density in patientswith type 1 diabetes mellitus. Joint Bone Spine.2000
  13. 67(3):215-8. 13.Kurra S, Siris E. Diabetes and bone health: the relati-onship between diabetes and osteoporosis-associatedfractures. Diabetes Metab Res Rev. 2011
  14. 27(5):430-5. 14.DeShields SC, Cunningham TD. Comparison of osteo-porosis in US adults with type 1 and type 2 diabetes mel-litus. J Endocrinol Invest. 2018. 15.Roy B. Biomolecular basis of the role of diabetes mel-li